Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Oncolytics Biotech, Inc’s current trading price is -22.22% away from its 52-week high, while its distance from the 52-week low is 265.25%. The stock’s price range over this period has fluctuated between $0.33 and $1.53. The company, operating within the financial sector, had a trading volume of approximately 0.96 million for the day, which was noticeably lower than the average daily share volume of 1.08 million over the last 3 months.
The stock of Oncolytics Biotech, Inc (ONCY) is currently priced at $1.19. In the last session, the stock climbed significantly, topping out at $5.04 after opening at $1.19. The day’s lowest price was $3.09 before the stock closed at $1.24.
Oncolytics Biotech, Inc experienced a rather steady stock market performance. The highest value in the past year was recorded at $1.53 on 10/07/24 and the lowest value was $0.33 on 06/06/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Oncolytics Biotech, Inc (ONCY) has experienced a quarterly rise of 98.93% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 114.95M and boasts a workforce of 28 employees.
Oncolytics Biotech, Inc: What Analysts Are Saying
As of right now, 1 analyst is rating Oncolytics Biotech, Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.6489, with a change in price of +0.5058. Similarly, Oncolytics Biotech, Inc recorded 791,500 in trading volume during the last 100 days, posting a change of +73.93%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ONCY stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.11.
ONCY Stock Stochastic Average
Today, Oncolytics Biotech, Inc’s raw stochastic average for the past 50 days stands at 84.38%, indicating a rise from the raw stochastic average of the last 20 days, which was 76.81%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 81.36% and 85.50% respectively.
ONCY Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 15.53% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 42.34%. Over the past 30 days, the price of ONCY has fallen by 86.81%. And in the last five days, it has fallen by -4.80%.
